Fabry Disease

Download PDF

Recent Publications on Fabry Disease:
Structural characterization of mutant alpha-galactosidases causing Fabry disease. Fabry disease is an inborn error of glycolipid catabolism resulting from...	18th July, 2008	Department of Analytical Biochemistry, Meiji Pharmaceutical University,	J Hum Genet. 2008 Jul 17;. DOI Direct Link
A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble? We present the case of a 36-year-old woman affected with Fabry disease...	18th July, 2008	Department of Neurological Sciences and Vision, Section of Clinical	Mult Scler. 2008 Jul 16;. DOI Direct Link
Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement. AIM: The aim of this study was to document exercise capacity and serial...	11th July, 2008	Department of Nephrology, Royal Melbourne Hospital, Melbourne, Victoria,	Intern Med J. 2008 Jun;38(6):407-14. DOI Direct Link
Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry. Fabry disease is an X-linked lysosomal disease caused by deficiency of...	4th July, 2008	Divisions of Human Genetics [R.J.H.], Division of Nephrology and	Pediatr Res. 2008 Jun 25;. DOI Direct Link
Two-tier approach for the detection of alpha-galactosidase A deficiency in kidney transplant recipients. BACKGROUND: Anderson-Fabry disease (AFD) is an X-linked condition...	4th July, 2008	1Department of Nephrology, Ghent University Hospital, Ghent.	Nephrol Dial Transplant. 2008 Jul 2;. DOI Direct Link
→View more research publications.

BioNews Results for Fabry Disease:
Rare diseases: what's next?	Lancet:  Jun 13 2008 1:40AM Matching: fabry disease

Fabry Disease Clinical Trials:
Canadian Fabry Disease Initiative (CFDI) Enzyme Replacement Therapy (ERT) Study	Fabry Disease

Fabry Disease Patents:
US Patent No.	Title
7214660	Erythropoietin: remodeling and glycoconjugation of erythropoietin
7268123	Derivatives of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)alkyl]phosphonic acid and methods of making them
7276475	Remodeling and glycoconjugation of peptides
7279553	PRO1083 polypeptides
7282222	Methods and compositions for directing cells to target organs
→View more patents.

Companies working in the area of Fabry Disease from Bioportfolio's Biocorporate database :
Company Name
Transkaryotic Therapies Incorporated RKT Founded in 1988, Transkaryotic Therapies, Inc. (TKT) is a leading biopharmaceutical company in the production and delivery of protein therapies. TKT develops, and intends to commercialize, protein... www.tktx.com/        View full profile

BioPortfolio Ltd. offers e-mail and postal lists for Fabry Disease scientists - we have details of around 180 individuals working on Fabry Disease .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.